Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pharmacyclics Inc (PCYC)    
$217.82 29.37 (15.59%) as of 4:30 Thu 2/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 73,583,000 as of 6/30
Market Cap: 16.03(B)
Last Volume: 3,254,077 Avg Vol: 840,343
52 Week Range: $85.85 - $217.82
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Pharmacyclics is a biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. Co. has three proprietary drug candidates under clinical development and several preclinical lead molecules: an inhibitor of Bruton's tyrosine kinase (BTK) ibrutinib in several Phase III studies in hematologic malignancies, a BTK inhibitor lead optimization program targeting anti-inflammatory and autoimmune indications, an inhibitor of Factor VIIa in a Phase II clinical trial in pancreatic cancer and a histone deacetylase inhibitor, abexinostat, in Phase I and II clinical trials in solid tumors and hematological malignancies.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 54,482 246,914 442,380
Total Sell Value $0 $7,191,273 $33,686,734 $52,879,841
Total People Sold 0 4 11 13
Total Sell Transactions 0 10 23 34
End Date 2014-11-27 2014-08-26 2014-02-25 2013-02-25

   
Records found: 388
  Page 1 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Booth Robert F. Director   –       •      –    2015-01-22 4 A $0.00 $0 D/D 10,000 10,000     -
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2015-01-16 4 A $0.00 $0 D/D 22,000 60,611     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2015-01-16 4 A $0.00 $0 D/D 15,000 225,312     -
   Duggan Robert W Chairman and CEO   •       •       •   2014-12-05 5 D $0.00 $0 I/I (200,740) 170,379     -
   Duggan Robert W Chairman and CEO   •       •       •   2014-12-04 5 GD $0.00 $0 D/D 617 13,382,951     -
   Duggan Robert W Chairman and CEO   •       •       •   2014-12-03 5 GD $0.00 $0 D/D 2,000 13,383,568     -
   Duggan Robert W Chairman and CEO   •       •       •   2014-11-19 5 GD $0.00 $0 D/D 35,517 13,385,568     -
   Tomasello Shawn Chief Commercial Officer   •       –      –    2014-11-19 4 D $138.37 $745,801 D/D (5,390) 57,110     -
   Duggan Robert W Chairman and CEO   •       •       •   2014-11-18 5 GD $0.00 $0 D/D 2,000 13,421,085     -
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2014-11-13 4 S $141.44 $141,442 D/D (1,000) 38,611 -37%     
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2014-11-13 4 OE $61.60 $61,600 D/D 1,000 39,611     -
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-11-13 4 OE $6.84 $20,520 D/D 3,000 6,193     -
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-11-13 4 S $141.30 $423,902 D/D (3,000) 3,193 -37%     
   Duggan Robert W Chairman and CEO   •       •       •   2014-11-13 5 GD $0.00 $0 D/D 1,504 13,423,085     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-11-12 4 OE $7.19 $42,644 D/D 5,931 216,243     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-11-12 4 S $137.50 $818,216 D/D (5,931) 210,312 -37%     
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-11-10 4 OE $2.30 $52,900 D/D 23,000 233,312     -
   Love Richard B General Counsel   •       –      –    2014-11-10 4 S $133.87 $200,805 D/D (1,500) 205 -41%     
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-11-10 4 S $133.50 $3,078,027 D/D (23,000) 210,312 -41%     
   Love Richard B General Counsel   •       –      –    2014-11-10 4 OE $32.38 $48,570 D/D 1,500 1,705     -
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-11-07 4 S $134.50 $672,500 D/D (5,000) 3,193 -37%     
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-11-07 4 OE $6.84 $34,200 D/D 5,000 8,193     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-11-07 4 S $135.01 $209,401 D/D (1,551) 210,312 -37%     
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-11-07 4 OE $2.30 $3,567 D/D 1,551 211,863     -
   Tan Heow Chief Quality&Tech Operations   •       –      –    2014-10-31 4 A $80.93 $81 D/D 1 4,070     -

  388 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed